WeLeader Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,388	3,243	-	-	-
Enterprise Value	3,916	3,845	-	-	-
Last Close Price	74.50	73.70	-	-	-
PE Ratio	18.35	19.05	-	-	-
PS Ratio	3.32	3.27	-	-	-
PB Ratio	3.12	3.57	-	-	-
P/TBV Ratio	3.13	3.59	-	-	-
P/FCF Ratio	23.36	30.01	-	-	-
P/OCF Ratio	11.15	11.63	-	-	-
EV/Sales Ratio	3.83	3.88	-	-	-
EV/EBITDA Ratio	11.68	15.83	-	-	-
EV/EBIT Ratio	17.97	17.96	-	-	-
EV/FCF Ratio	27.00	35.59	-	-	-
Debt / Equity Ratio	0.67	0.88	0.74	1.09	0.79
Debt / EBITDA Ratio	2.17	2.47	2.07	2.30	1.14
Debt / FCF Ratio	5.01	7.37	5.34	-	1.30
Asset Turnover	-	0.53	0.56	0.83	-
Inventory Turnover	-	8.00	9.71	12.54	-
Quick Ratio	1.16	1.04	0.94	0.89	1.13
Current Ratio	1.46	1.26	1.12	1.04	1.29
Return on Equity (ROE)	-	19.41%	20.41%	30.64%	-
Return on Assets (ROA)	-	7.18%	7.43%	9.80%	-
Return on Capital (ROIC)	-	8.43%	8.78%	12.24%	-
Return on Capital Employed (ROCE)	12.80%	14.00%	14.90%	16.80%	25.50%
Earnings Yield	5.17%	5.25%	-	-	-
FCF Yield	4.28%	3.33%	-	-	-
Dividend Yield	4.52%	4.57%	-	-	-
Payout Ratio	141.97%	56.18%	19.54%	6.35%	21.14%
Buyback Yield / Dilution	-3.69%	-1.55%	-35.00%	-8.28%	-
Total Shareholder Return	0.83%	3.02%	-35.00%	-8.28%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.